Full text
PDF![1277](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5660/291042/068ce7800a7f/jcinvest00315-0095.png)
![1278](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5660/291042/c2834beaa376/jcinvest00315-0096.png)
![1279](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5660/291042/da77e722d7a2/jcinvest00315-0097.png)
![1280](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5660/291042/c67498877500/jcinvest00315-0098.png)
![1281](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5660/291042/eae5422761ee/jcinvest00315-0099.png)
![1282](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5660/291042/f43ea8e37693/jcinvest00315-0100.png)
![1283](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5660/291042/ddddaca84297/jcinvest00315-0101.png)
![1284](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5660/291042/b8dfa067de52/jcinvest00315-0102.png)
![1285](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5660/291042/d4375911f6e4/jcinvest00315-0103.png)
![1286](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5660/291042/c41331f7e203/jcinvest00315-0104.png)
![1287](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5660/291042/760487b4c58b/jcinvest00315-0105.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALKJAERSIG N., FLETCHER A. P., SHERRY S. The activation of human plasminogen. I. Spontaneous activation in glycerol. J Biol Chem. 1958 Jul;233(1):81–85. [PubMed] [Google Scholar]
- ALKJAERSIG N., FLETCHER A. P., SHERRY S. xi-Aminocaproic acid: an inhibitor of plasminogen activation. J Biol Chem. 1959 Apr;234(4):832–837. [PubMed] [Google Scholar]
- ASTRUP T. Fibrinolysis in the organism. Blood. 1956 Sep;11(9):781–806. [PubMed] [Google Scholar]
- ASTRUP T., MULLERTZ S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys. 1952 Oct;40(2):346–351. doi: 10.1016/0003-9861(52)90121-5. [DOI] [PubMed] [Google Scholar]
- ASTRUP T., STERNDORFF I. Fibrinolysokinase activity in animal and human tissue. Acta Physiol Scand. 1956 Jul 17;37(1):40–47. doi: 10.1111/j.1748-1716.1956.tb01340.x. [DOI] [PubMed] [Google Scholar]
- BECKER E. L. Inactivation of Hageman factor by diisopropylfluorophosphate (DFP). J Lab Clin Med. 1960 Jul;56:136–138. [PubMed] [Google Scholar]
- FERGUSON J. H., WILSON E. G., IATRIDIS S. G., RIERSON H. A., JOHNSTON B. R. Enzymes and blood clotting. I. Trypsin as an accessory factor. J Clin Invest. 1960 Dec;39:1942–1952. doi: 10.1172/JCI104219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HARDISTY R. M., MARGOLIS J. The role of Hageman factor in the initiation of blood coagulation. Br J Haematol. 1959 Apr;5(2):203–211. doi: 10.1111/j.1365-2141.1959.tb04026.x. [DOI] [PubMed] [Google Scholar]
- JOHNSTON C. L., Jr, FERGUSON J. H., O'HANLON F. A. Surface activation of plasma clotting: a function of Hageman factor. Proc Soc Exp Biol Med. 1958 Oct;99(1):197–201. doi: 10.3181/00379727-99-24294. [DOI] [PubMed] [Google Scholar]
- KLINE D. L. The purification and crystallization of plasminogen (profibrinolysin). J Biol Chem. 1953 Oct;204(2):949–955. [PubMed] [Google Scholar]
- KWAAN H. C., LO R., MCFADZEAN A. J. On the production of plasma fibrinolytic activity within veins. Clin Sci. 1957 May;16(2):241–253. [PubMed] [Google Scholar]
- KWAAN H. C., LO R., McFADZEAN A. J. On the inhibition of plasma fibrinolytic activity by exercised ischaemic muscles. Clin Sci. 1958;17(2):361–368. [PubMed] [Google Scholar]
- KWAAN H. C., LO R., McFADZEAN J. S. On the lysis of thrombi experimentally produced within veins. Br J Haematol. 1958 Jan;4(1):51–62. doi: 10.1111/j.1365-2141.1958.tb03833.x. [DOI] [PubMed] [Google Scholar]
- LEWIS J. H., FERGUSON J. H. Studies on a proteolytic enzyme system of the blood. Activation of profibrinolysin by serum fibrinolysokinase. Proc Soc Exp Biol Med. 1951 Oct;78(1):184–188. doi: 10.3181/00379727-78-19014. [DOI] [PubMed] [Google Scholar]
- MULLERTZ S. Activation of plasminogen. Ann N Y Acad Sci. 1957 Aug 30;68(1):38–51. doi: 10.1111/j.1749-6632.1957.tb42611.x. [DOI] [PubMed] [Google Scholar]
- MULLERTZ S. Formation and properties of the activator of plasminogen and of human and bovine plasmin. Biochem J. 1955 Nov;61(3):424–434. doi: 10.1042/bj0610424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NIEWIAROWSKI S., PROU-WARTELLE O. [Role of the contact factor (Hageman factor) in fibrinolysis]. Thromb Diath Haemorrh. 1959 Sep 1;3:593–603. [PubMed] [Google Scholar]
- RATNOFF O. D., DAVIE E. W., MALLETT D. L. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. J Clin Invest. 1961 May;40:803–819. doi: 10.1172/JCI104314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SAWYER W. D., FLETCHER A. P., ALKJAERSIN N., SHERRY S. Studies on the thrombolytic activity of human plasma. J Clin Invest. 1960 Feb;39:426–434. doi: 10.1172/JCI104054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SHERRY S., FLETCHER A. P., ALKJAERSIG N. Fibrinolysis and fibrinolytic activity in man. Physiol Rev. 1959 Apr;39(2):343–382. doi: 10.1152/physrev.1959.39.2.343. [DOI] [PubMed] [Google Scholar]
- SOULIER J. P., WARTELLE O., MENACHE D. Caractères différentiels des facteurs Hageman et P.T.A. ; rôle du contact dans la phase initiale de la coagulation. Rev Fr Etud Clin Biol. 1958 Mar;3(3):263–267. [PubMed] [Google Scholar]